Evidence map›Paper›PMID 42175820›Full record

ArticleStatistical methods in medical research2026

A quantile cure model with partially functional covariate effects.

Chyong-Mei Chen, Yingwei Peng

Abstract read
In one paragraph

Article in Statistical methods in medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Chyong-Mei ChenInstitute of Public Health, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan ROC.ORCID 0000-0001-6824-4819
Yingwei PengDepartment of Public Health Sciences, Queen's University, Kingston, ON, Canada.ORCID 0000-0001-7391-9788

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Quantile regressions offer several attractive features, including the ability to allow covariate effects to vary at different quantile levels and to effectively handle heteroscedasticity in data, which makes it a viable alternative for analyzing data with continuous outcomes in recent years. It has been used in modeling survival data with and without a cured fraction. In this work, we propose novel estimating equation approaches to estimate a mixture cure model where the latency survival time is modeled using a quantile regression. Our proposed estimation methods provide double robustness, meaning that a misspecification in one part of the mixture cure model will not affect the estimation in the other part. The methods relax the restrictive global log-linear assumption that is typically found in existing quantile regressions, and they allow for both quantile-varying and quantile-invariant effects in the regression when the log-linear assumption holds within a certain range of quantile levels. We established the asymptotic properties of the proposed estimators, and our simulation studies demonstrated their double robustness and efficiency gains. An application of the proposed model and methods to data from a lung cancer study revealed that uncured patients with adenocarcinoma have significantly longer quantiles in the survival time than uncured patients with squamous cell carcinoma, which had not been reported in previous analyses of the data due to the limitations of the existing methods.

Indexed as

Models, StatisticalAdenocarcinomaComputer SimulationHumansLung NeoplasmsRegression AnalysisSurvival AnalysisEstimating equationinverse probability censoring weightinglung cancermixture cure modelquantile regression model

Identifiers

PMID42175820
PMCPMC13283496

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.